CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 54 enrolled
Drug / intervention
Fractional Radiofrequency (FRF)device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03467724
NCT03467724N/ACompleted

Clinical Evaluation of the Safety and Performance of Fractional RF for the Treatment of Surgical Scars Following Breast Augmentation, Abdominoplasty or Face Lift

Venus Concept·interventional·Posted Mar 16, 2018·Updated Jul 29, 2024

In Brief

A clinical study evaluating Fractional Radiofrequency (FRF) for Surgical Scar and 3 related conditions. Completed, enrolled 54 participants across 1 site.

Detailed Summary

Evaluator-blinded study of the safety and performance of fractional radiofrequency (FRF) for the treatment of surgical scars following breast augmentation, abdominoplasty or facelift. The study will enroll up to 50 female subjects requesting treatment of surgical scars following breast augmentation or abdominoplasty and up to 25 male and female subjects requesting treatment of surgical scars following facelift surgery. Subjects will receive a total of 3 treatments of their surgical scars at 1-month intervals. Subjects will be followed up at 10 months after their last treatment (12 months after the first treatment).

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesSpain
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedMar 16, 2018
Enrollment StartJan 23, 2018
Primary CompletionApr 13, 2020
TodayJul 2, 2026
Enrollment to primary: 2.2 yearsPosted 8.3 years ago

Interventions

Fractional Radiofrequency (FRF)device

Fractional radiofrequency will be delivered to the area of the surgical scar.